Skip to main content

Advertisement

Log in

Theoretic scientific rationale of double XEN 45 Gel Stent implant in severe glaucomatous ocular hypertension

  • Original Paper
  • Published:
International Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the theoretical hydrodynamic effects of a single or a double XEN 45 Gel Stent (XEN45) implant in glaucomatous eyes.

Methods

A prospective non-randomized clinical study on 63 glaucomatous eyes of 63 patients. The preoperative intraocular pressure (IOP) values after 14 days of medical therapy washout was correlated to the postoperative IOP values 7 and 45 days after the implant of a XEN45.

A mathematical model based on the Hagen-Poiseuille law was designed to assess the residual aqueous humor outflow (AHO) facility in glaucomatous eyes in function of the postoperative IOP reduction. Using XEN45 as unit of measurement, we transformed through equations the residual preoperative AHO in XEN45 equivalent in order to establish theoretical number of stents needed to reach the target IOP.

Results

The mean preoperative washout IOP was 28.9 ± 5.4 mmHg, after 7 and 45 days the mean postoperative IOP was 12.6 ± 4.3 and 15.3 ± 4.4 mmHg, respectively (p < 0.001). A significant positive correlation was found between preoperative and postoperative IOP values. We obtained a mathematical relationship to estimate the theoretical number of XEN45 stents needed to reach the target IOP.

Conclusion

The basal IOP (after medical therapy washout) is a predictive factor for the surgical success after a XEN45 implant. Establishing the residual preoperative AHO it is possible to predict the theoretical number of stents to implant.

A double XEN45 implant could be considered a possible further tool to reach the target IOP in patients with severe AHO deficiency.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Millar C, Kaufmann PL (1995) Aqueous humor: secretion and dynamics in Duane’s foundations of clinical Ophthalmology. Lippincott-Raven

    Google Scholar 

  2. Goel M, Picciani RG, Lee RK, Bhattacharya S (2010) Aqueous humor dynamics: a review. Open Ophthalmol J 4:52–59

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Brubaker RF (1991) Flow of aqueous humor in humans. Invest Ophthalmol Vis Sci 32:3145–3166

    CAS  PubMed  Google Scholar 

  4. McLaren JW (2009) Measurement of aqueous humor flow. Exp Eye Res 88:641–647

    Article  CAS  PubMed  Google Scholar 

  5. Kaufman PL (1996) Pressure-dependent outflow. In: Ritch R (ed) The glaucomas, 2nd edn. CV Mosby, St Louis, p 307

    Google Scholar 

  6. Saheb H, Ahmed II (2012) Micro-invasive glaucoma surgery: current perspectives and future directions. Curr Opin Ophthalmol 23:96–104

    Article  PubMed  Google Scholar 

  7. Richter GM, Coleman AL (2016) Minimally invasive glaucoma surgery: current status and future prospects. Clin Ophthalmol 10:189–206

    PubMed  PubMed Central  Google Scholar 

  8. Vera V, Horvath C (2014) XEN gel stent: the solution designed by AqueSys®. In: Samples JR, Ahmed IIK (eds) Surgical innovations in glaucoma. Springer, New York

    Google Scholar 

  9. Lewis RA (2014) Ab interno approach to the subconjunctival space using a collagen glaucoma stent. J Cataract Refract Surg 40:1301–1306

    Article  PubMed  Google Scholar 

  10. Sheybani A, Lenzhofer M, Hohensinn M, Reitsamer H, Ahmed II (2015) Phacoemulsification combined with a new ab interno gel stent to treat open-angle glaucoma: pilot study. J Cataract Refract Surg 41:1905–1909

    Article  PubMed  Google Scholar 

  11. Shute TS, Dietrich UM, Baker JF et al (2016) Biocompatibility of a novel microfistula implant in non primate mammals for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci 57:3594–3600

    Article  CAS  PubMed  Google Scholar 

  12. Sheybani A, Dick B, Ahmed II (2016) Early clinical results of a novel Ab interno gel stent for the surgical treatment of open-angle glaucoma. J Glaucoma 25(7):e691–e696

    Article  PubMed  Google Scholar 

  13. Sheybani A, Reitsamer H, Ahmed II (2015) Fluid dynamics of a novel microfistula implant for the surgical treatment of glaucoma. Invest Ophthalmol Vis Sci 56:4789–4795

    Article  CAS  PubMed  Google Scholar 

  14. Pérez-Torregrosa VT, Olate-Pérez Á, Cerdà-Ibáñez M et al (2016) Combined phacoemulsification and XEN45 surgery from a temporal approach and 2 incisions. Arch Soc Esp Oftalmol 91:415–421

    Article  PubMed  Google Scholar 

  15. De Gregorio A, Pedrotti E, Russo L, Morselli M (2017) Minimally invasive combined glaucoma and cataract surgery: clinical results of the smallest Ab interno gel stent. Int Ophtalmol 38:1129–1134

    Article  Google Scholar 

  16. Shaarawy T, Sherwood MB, Grehn F (2009) Guidelines on design and reporting of glaucoma surgical trials. Kugler Publications, Amsterdam

    Google Scholar 

  17. Brusini P, Filacorda S (2006) Enhanced glaucoma staging system (GSS 2) for classifying functional damage in glaucoma. J Glaucoma 15:40–46

    Article  PubMed  Google Scholar 

  18. De Gregorio A, Pedrotti E, Stevan G et al (2018) XEN glaucoma treatment system in the management of refractory glaucomas: a short review on trial data and potential role in clinical practice. Clin Ophthalmol 12:773–782

    Article  PubMed  PubMed Central  Google Scholar 

  19. Samples JR, Ahmed II (2020) Current developments in glaucoma surgery and MIGS. Kugler Publications

    Google Scholar 

Download references

Acknowledgements

Special thanks to Eng. Marcello Montali for the scientific support with the mathematical analysis.

Funding

The authors declare that no funds, grants or other support were received during the preparation of this manuscript.

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study conception and design. Material preparation, data collections and analyses were performed by ADG, MM and GS. The first draft of the manuscript was written by ADG and MM. EP and SM: revised and approved the final version to be published.

Corresponding author

Correspondence to Alessandra De Gregorio.

Ethics declarations

Conflict of interest

The authors have no relevant financial or non-financial interests to disclose.

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent to publish

The authors affirm that human research participants provided informed consent for publication of the images in Fig. 4.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki and did not require ethical approval since all patients were treated and followed as routine clinical practice.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

De Gregorio, A., Montali, M., Stevan, G. et al. Theoretic scientific rationale of double XEN 45 Gel Stent implant in severe glaucomatous ocular hypertension. Int Ophthalmol 43, 1629–1638 (2023). https://doi.org/10.1007/s10792-022-02561-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10792-022-02561-6

Keywords

Navigation